Strategic focus Target a small biotech firm with strong leadership and a focus on disease system modeling and QSP, highlighting ISB's competitive advantage in computational disease modeling to support drug discovery and development pipelines.

Global engagement Capitalize on recent international activity such as presenting at QSPainRelief in the Netherlands to propose partnerships or advisory services for cross-border collaborations and access to European research networks.

Funding signal Revenue in the low-to-mid six figures to low seven figures suggests budget readiness for pilot projects, proof-of-concept collaborations, or platform licensing for computational modeling and data analytics.

Tech compatibility Leverage ISB’s tech stack (Cloud, JSON-LD, Open Graph, WordPress, Shopify) to propose integrated solutions, data sharing, and customer-facing platforms that streamline collaboration, reporting, and commercialization.

Market positioning Position ISB beside mid-sized competitors with scalable disease modeling capabilities, offering cost-effective, nimble engagement for early-stage trials or academic-industrial partnerships that require rapid modeling studies.